Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
        • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
      • Recently Published Guidelines
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
      • Brigham and Women's Hospital
      • Hartford Hospital
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Instituto do Coração-INCOR (São Paulo, Brasil)
      • Minneapolis City Hospital
      • Parkland Hospital: Dallas, Texas
      • Pennsylvania Hospital, Philadelphia
      • Pitié-Salpêtrière Hospital
      • Royal Infirmary of Edinburgh, Scotland
      • Tufts Medical Center
      • University of Michigan
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
      • Women's College Hospital, Toronto, Canada
      • Henry Ford Hospital, Detroit, Michigan
      • Instituto Nacional de Cardiología Ignacio Chávez – INCICh México City, México
      • Kuang-Tien General Hospital (Taichug, Taiwan)
      • University Hospital “Policlinico Umberto I”
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Articles

Fiber, Lipids, and Coronary Heart Disease

A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association

Linda Van Horn
https://doi.org/10.1161/01.CIR.95.12.2701
Circulation. 1997;95:2701-2704
Originally published June 17, 1997
Linda Van Horn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • What Is Dietary Fiber?
    • Sources of Dietary Fiber
    • Mechanisms of Serum Cholesterol Reduction
    • Fiber Intake and Mortality
    • Results of Clinical and Metabolic Studies
    • Effects of Fiber on Other Risk Factors
    • Fiber and Children’s Diets
    • Conclusions
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • AHA Medical/Scientific Statements
  • diet
  • lipids
  • coronary disease

There is now overwhelming evidence that dietary factors influence risk of coronary heart disease (CHD) both favorably and unfavorably.1 2 3 4 The three most atherogenic dietary risk factors are saturated fat, cholesterol, and obesity.2 3 The Step I and Step II diets are recommended to address these problems and are aimed at reducing intake of total fat, saturated fat, and cholesterol. On average, blood cholesterol levels can be reduced an estimated 5% to 15% through the Step I–Step II diet approach, with some hyperlipidemic patients experiencing even greater reductions. Increased carbohydrate intake, especially complex carbohydrates, is also recommended to replace the majority of calories lost through reduced fat intake. Choosing fiber-rich carbohydrate sources may foster additional cholesterol lowering and other nutritional benefits beyond those derived from fat modification alone. Inconsistent findings from studies on fiber and lipids have recently contributed to some confusion regarding fiber’s potential benefits. Current evidence regarding this subject and limitations of the existing literature are briefly reviewed.

What Is Dietary Fiber?

The Life Sciences Research Office of the Federation of American Societies for Experimental Biology defines fiber as “the endogenous components of plant materials in the diet which are resistant to digestion by enzymes produced by humans.”4 Simply put, dietary fiber, including cellulose, hemicelluloses, pectin, and lignin, comes from the cell walls of plants plus other indigestible components of plants. Much of the difficulty in defining specific types of fiber is related to differences in analytical methodology used to quantify it.

Only as recently as the late 1970s was it recognized that fiber could be characterized by its solubility in the intestines.5 6 Nutrient tables developed before 1980 contain primarily crude fiber values. Crude fiber is measured after an exhaustive extraction of foods and does not provide an accurate estimate of the actual dietary fiber content of foods. In the United States the method developed by Prosky et al7 has been accepted by the Association of Analytical Chemists, is widely used, and provides a reliable estimate for total fiber content of foods. In the United Kingdom a method for determining nonstarch polysaccharides has been developed and is commonly used for assessing fiber content. These methods yield some slight differences in total fiber content, but they are relatively close in their estimation and far more accurate than the crude fiber assays of old.

One of the physical characteristics of polysaccharides is the ability to swell and hold water within a matrix. Fibers with a high water-holding capacity, such as pectin, gums, and psyllium, have been referred to as soluble fiber. Because it was presumed that defining the characteristics of fibers by their soluble and insoluble classification could facilitate distinction in biological responses, methods were developed to measure each of these fiber fractions. Improved methods for soluble fiber determination have resulted in increased accuracy regarding content, but it has since become evident that the physiological response to fiber sources based on this measurement is not necessarily predictable on the basis of solubility alone. Other factors, such as fermentability, viscosity, and bile acid binding ability, also contribute to the physiological response to fiber sources. Additionally, since all foods contain a mixture of polysaccharides, only isolated polysaccharides can be simply classified as soluble or insoluble fiber sources.

Despite the potential confounding of these classifications, both soluble and insoluble forms of fiber are important and appear to have different health properties in at least some settings.5 6 8 The AHA dietary guidelines for Americans3 emphasize the importance of consuming a variety of fiber sources to obtain the different types of fibers found in foods. Fiber is important for gastrointestinal health as well as cholesterol-lowering benefits. Foods containing fiber are good sources of several other essential nutrients, and, depending on the method of preparation, these foods are typically low in fat, saturated fatty acids, and cholesterol as well.

Sources of Dietary Fiber

Because of these limitations in chemical assessment methodology, quantifying dietary fiber composition of the food supply has historically been difficult and limited to crude fiber only. Within the past decade food composition databases have reflected technological advances by listing specific values for total, soluble, and insoluble dietary fiber. Wheat, rye, rice, and most other grains are primarily composed of insoluble fiber.9 10 Oats have a greater proportion of soluble fiber than any other grain. Barley offers both but is mainly insoluble fiber. Legumes, beans, and peas are also excellent sources of both soluble and insoluble fiber, with almost 7 g of total fiber and 2 g of soluble fiber in a one-half cup serving. Certain fruits and vegetables are better sources of both soluble and insoluble fiber than others. Usually more of these foods must be consumed to equal the fiber contributions of either beans or cereal grains. Table 1⇓ provides some examples across food groups. Choosing foods from all these groups ensures adequate intake of both types of fiber in a ratio of about 1 part soluble to 3 parts insoluble fiber. Numerous other nutrients are contributed by these foods as well, usually without adding fat or excessive calories.

View this table:
  • View inline
  • View popup
Table 1.

Selected Sources and Amounts of Dietary Fiber

Mechanisms of Serum Cholesterol Reduction

Specific mechanisms involved in serum cholesterol reductions observed with increased fiber intake remain somewhat inconclusive. Recent research provides evidence that viscous polysaccharides act in the gastrointestinal tract to reduce blood cholesterol by decreasing absorption of cholesterol or fatty acids and decreasing absorption of biliary cholesterol or bile acids.11 12 Fiber may also cause altered serum concentration of hormones or short-chain fatty acids that affect lipid metabolism. β-Glucan, the water-soluble fiber prevalent in oats and barley, has been shown in animal models to be the active agent causing the altered cholesterol metabolism.13

On the basis of results of studies of oats and barley, other proposed mechanisms include the influence of ∝-tocotrienols and compounds that have vitamin E activity and produce hepatic HMG-CoA (hydroxymethylglutaryl coenzyme A) reductase inhibition in animal models, but this has yet to be conclusively documented.14 It has been further suggested that the amino acid content of oats and the arginine-lysine ratio may also promote the hypocholesterolemic response.15 16 Further studies in humans are needed to delineate and quantify these mechanisms across different fiber sources and under different biological conditions.

Fiber Intake and Mortality

Several longitudinal observational studies have reported significant inverse associations between total fiber intake and both cardiovascular and all causes of mortality.17 18 Part of this phenomenon may reflect the accompanying inverse association that is often observed between fiber and fat intake when calories are controlled.19 For example, in the Zutphen Study,18 men in the lowest quintile of dietary fiber intake exhibited a four times higher rate of CHD mortality compared with men in the highest quintile, even though total caloric intake was about the same. Numerous studies comparing vegetarians and nonvegetarians have reported lower levels of serum cholesterol and lower mortality rates in the former, but whether fiber is the active agent involved or simply a reflection of greater intake of complex carbohydrates and less saturated fat is not easily deciphered.20 21 22

Other epidemiological evidence is less consistent. The rate of CHD mortality was reported to be inversely associated with fiber intake across 20 industrialized nations, but adjustment for fat intake removed the association.23 Similarly a 20-year cohort study of 1001 middle-aged men in Ireland and Boston reported significant inverse association between fiber intake and risk of CHD, but the association diminished when other risk factors were controlled.24 In a 12-year follow-up study of 859 men and women aged 50 to 79 years, a 6-g increment in daily fiber intake was associated with a 25% reduction in ischemic heart disease mortality, independent of calories, fat, and other dietary variables.25 A recent study among 850 men in the Yi province of China reported that lower serum cholesterol and blood pressure levels were associated with higher intakes of fiber from oats and buckwheat.26 Total fat and dietary cholesterol intakes were also significantly lower in those with the highest fiber intakes, but caloric intakes were similar across all fiber groups. These studies and others illustrate the complexity of measuring the independent impact of fiber on lipids and/or mortality rates within the limitations of available diet assessment methodology, disparate food composition data, and the difficulty of controlling confounding factors.27

Results of Clinical and Metabolic Studies

A growing number of metabolic research studies have reported total cholesterol reductions of 10% to 15% with diets enriched with fiber from oats,28 29 30 beans,31 32 or psyllium,33 but these diets were also reduced in fat. Other studies have investigated adding supplements of pectin and guar gum with subsequent cholesterol reductions of 10% or more, but gastrointestinal side effects were more common.19 34 35

In the past decade more than 30 clinical studies have evaluated the impact of oats and other fiber-rich foods as part of Step I or similar fat-modified diets in outpatient, free-living, and controlled settings. The majority of studies report the greatest lipid-lowering benefits occur among persons with elevated baseline cholesterol levels. A meta-analysis of pooled data from 13 randomized, controlled trials with baseline and follow-up dietary data further controlled for the impact of the fat-modified diet alone. Fiber from two servings of oats enhanced cholesterol reduction by an additional 2% to 3% beyond what was achieved by fat modification.36

Some studies on dietary fiber and lipid response have reported equivocal results.37 38 39 In its review of evidence to determine whether to approve a food manufacturer’s petition for a health claim that links increased oat fiber intake with cholesterol lowering, the Food and Drug Administration 40 applied rigorous evaluation criteria to all available data. Studies that did not support the soluble fiber lipid-lowering relation were often criticized for small sample sizes, inadequate dietary data to evaluate adherence to the recommended diet, and/or lack of standardized sources of fiber. Of all the studies reviewed, the majority favored the association with doses ranging from 34 g total dietary fiber (2.5 g soluble fiber) to 123 g (10.3 g soluble fiber). 40 A dose-response study specifically designed to evaluate this question among hypercholesterolemic persons found maximal lipid lowering was achieved with 56 g versus 84 g of oat bran, suggesting a possible threshold effect.15 Fifty-six grams of oat bran is equivalent to approximately two servings (two-thirds cup dry).

Studies of fiber supplements containing psyllium have reported greater reductions of 15% in LDL-cholesterol levels as part of the usual American diet and 9% as part of a Step I diet.33 More recently a fiber supplement containing a mixture of guar gum, pectin, soy fiber, pea fiber, and corn bran lowered LDL cholesterol by 7% to 8% in hypercholesterolemic participants after 15 weeks compared with those taking a placebo.41 These reductions persisted throughout the 51-week follow-up period with continued use of supplements. Potential risks of excessive use of fiber supplements include reduced mineral absorption and a myriad of gastrointestinal disturbances. Fiber from natural dietary sources is preferred to avoid these problems and supply numerous other nutritional benefits. A fiber supplement added to a diet otherwise high in saturated fat and cholesterol provides dubious cardiovascular advantages. Indeed, such an approach can be detrimental if it instills a false sense of security that precludes further attention to other aspects of the diet, such as high saturated fat intake.

Observational epidemiological evidence consistently demonstrates lower incidence of CHD and other long-term diseases among those with the highest intake of fruits, vegetables, and grains.25 42 43 Such a dietary pattern appears to offer protective effects that transcend lipid lowering and overall is typically lower in total fat, saturated fat, and cholesterol.

Effects of Fiber on Other Risk Factors

Inverse associations between fiber and blood pressure have also been reported.44 45 46 Some intervention studies among hypertensive and normotensive individuals have reported reductions in blood pressure in response to increased fiber intake, but these results are not conclusive.8 47 48 Confounding factors in these studies include obesity, use and amount of antihypertensive medication, and comorbidity. A vegetarian diet appears to induce blood pressure reduction in hypertensive individuals, but independent effects of dietary fiber have yet to be elucidated.

Similarly, high-fiber vegetarian diets have also been associated with reduced risk of obesity.8 20 49 50 It has been hypothesized that high-fiber foods may favorably impact satiety and slow gastric emptying, thereby sustaining a feeling of fullness that prohibits overeating.6 8 Intake of high-fiber foods may also improve glycemic control in diabetic individuals and reduce risk of insulin resistance.1 51 Clinical trials to address each of these factors and isolate independent effects of fiber on weight control versus glucose metabolism are needed.

Fiber and Children’s Diets

As a preventive strategy, it has been recommended that children older than 2 years should gradually adopt the Step I diet, reducing total and saturated fat intake to 30% and 10% of total calories, respectively. Children should also derive the majority of calories from complex carbohydrates.2 Such a diet inherently offers the benefits of increased fiber and nutrient intake from a host of dietary sources as well, but lingering concerns about reduced energy intake and compromised growth have prompted suggested fiber guidelines from the pediatric community. It has been proposed that the “age plus 5” rule be applied when determining the appropriate amounts of dietary fiber for young children.52 This means, for example, a five-year-old should consume 5+5=10 g of fiber per day. This should be easy to accomplish within the boundaries of the Step I diet. Once a child’s caloric intake approaches that of an adult, ie, 1500 calories or more, 25 total grams should be well tolerated.

Conclusions

The greatest impact on lowering total and LDL cholesterol is derived from reduced intakes of saturated fat and cholesterol as well as weight reduction in obese persons. Diets high in complex carbohydrates and fiber are associated with reduced mortality rates from CHD and other chronic diseases. Fiber found in oats, barley, and pectin-rich fruits and vegetables provides adjunctive lipid-lowering benefits beyond those achieved by reductions in total and saturated fat alone. The AHA recommends a total dietary fiber intake of 25 to 30 g/d from foods, not supplements, to ensure nutrient adequacy and maximize the cholesterol-lowering impact of a fat-modified diet. Current dietary fiber intakes among adults in the United States average about 15 g, or half the recommended amount.53

Footnotes

  • ‘Fiber, Lipids, and Coronary Heart Disease’ was approved by the American Heart Association Science Advisory and Coordinating Committee in December 1996.

  • A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Avenue, Dallas, TX 75231-4596. Ask for reprint No 71-0113.

  • Copyright © 1997 by American Heart Association

References

  1. ↵
    National Academy of Sciences. Diet and Health. Washington, DC: National Academy Press; 1989.
  2. ↵
    National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Bethesda, Md: US Department of Health and Human Services; 1990. NIH publication 90-3046.
  3. ↵
    The Nutrition Committee, American Heart Association. Dietary guidelines for healthy American adults. Circulation. 1996;94:1795-1800.
    OpenUrlFREE Full Text
  4. ↵
    LSRO (Life Sciences Research Office). Physiological Effects and Health Consequences of Dietary Fiber. Bethesda, Md: Federation of American Societies for Experimental Biology; 1987:236.
  5. ↵
    Stephen A. Whole grains: impact of consuming whole grains on physiological effects of dietary fiber and starch. Cult Rev Food Sci Nutr. 1994;34(5,6):499-511.
  6. ↵
    Stephen A. Starch and dietary fiber: their physiological and epidemiological interrelationships. Cancer J Physiol. 1991;69:116-120.
  7. ↵
    Prosky L, Asp NG, Furda I, DeVries JW, Schweizer TF, Harland BF. Determination of total dietary fiber in foods and food products: collaborative study. J Assoc Off Anal Chem. 1985;68:677-679.
    OpenUrlPubMed
  8. ↵
    Anderson JW, Smith BM, Gustafson NJ. Health benefits and practical aspects of high-fiber diets. Am J Clin Nutr. 1994;59 (suppl):1242S-1247S.
  9. ↵
    Englyst H, Wiggins HS, Cummings JH. Determination of the non-starch polysaccharides in plant foods by gas-liquid chromatography of constituent sugars as alditol acetates. Analyst. 1982;107:307-318.
    OpenUrlPubMed
  10. ↵
    Southgate DA, Hudson GJ, Englyst H. The analysis of dietary fibre: the choices for the analyst. J Sci Food Agric. 1978;29:979-998.
    OpenUrlCrossRefPubMed
  11. ↵
    Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA. Mechanism of serum cholesterol reduction by oat bran. Hepatology. 1994;20:1450-1457.
    OpenUrlCrossRefPubMed
  12. ↵
    Anderson JW, Story L, Sieling B, Chen WJ, Petro MS, Story J. Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr. 1984;40:1146-1155.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Shinnick F, Mathews R, Ink S. Serum cholesterol reduction by oats and other fiber sources. Cereal Foods World. 1991;36:815-821.
    OpenUrl
  14. ↵
    Qureshi AA, Burger WC, Peterson DM, Elson CE. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem. 1986;261:10544-10550.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran: a dose-controlled study. JAMA. 1991;265(14):1833-1839.
  16. ↵
    Kritchevsky D. Dietary fiber and atherosclerosis. In: Vahouny GV, Kritchevsky D, eds. Dietary Fiber: Basic and Clinical Aspects. New York, NY: Plenum Press; 1986:265-274.
  17. ↵
    Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J. 1977;2:1307-1314.
  18. ↵
    Kromhout D, Bosschieter EB, de Lezenne Coulander C. Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes: the Zutphen Study. Lancet. 1982;1:518-522.
    OpenUrl
  19. ↵
    Anderson JW, Garrity TF, Wood CL, Whitis SE, Smith BM, Oeltgen PR. Prospective, randomized, controlled comparison of the effects of low-fat and low-fat plus high-fiber diets on serum lipid concentrations. Am J Clin Nutr. 1992;56:887-894.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Burslem J, Schonfeld G, Howald MA, Weidman SW, Miller JP. Plasma apoprotein and lipoprotein lipid levels in vegetarians. Metabolism. 1978;27:711-719.
    OpenUrlCrossRefPubMed
  21. ↵
    Knuiman JT, West CE. The concentration of cholesterol in serum and in various serum lipoproteins in macrobiotic, vegetarian and non-vegetarian men and boys. Atherosclerosis. 1982;43:71-82.
    OpenUrlCrossRefPubMed
  22. ↵
    Sacks FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med. 1975;292:1148-1151.
    OpenUrlPubMed
  23. ↵
    Liu K, Stamler J, Moss D, Garside D, Persky V, Soltero I. Dietary cholesterol, fat and fibre, and colon-cancer mortality: an analysis of international data. Lancet.. 1979;2:782-785.
    OpenUrlPubMed
  24. ↵
    Kushi LH, Lew RA, Stare FJ, Ellison CR, el Lozy M, Bourke G, Daly L, Graham I, Hickey N, Mulcahy R. Diet and 20-year mortality from coronary heart disease: the Ireland-Boston Diet-Heart Study. N Engl J Med. 1985;312:811-818.
    OpenUrlCrossRefPubMed
  25. ↵
    Khaw KT, Barrett-Connor E. Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol. 1987;126:1093-1102.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    He J, Klag MJ, Whelton PK, Mo JP, Chen JY, Qian MC, Mo PS, He GQ. Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China. Am J Clin Nutr. 1995;61:366-372.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Lanza E, Butrum RR. A critical review of food fiber analysis and data. J Am Diet Assoc. 1986;86:732-743.
    OpenUrlPubMed
  28. ↵
    Kirby RW, Anderson JW, Sieling B, Rees ED, Chen WJ, Miller RE, Kay RM. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr. 1981;34:824-829.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Anderson JW, Story L, Sieling B, Chen WJ, Petro MS, Story J. Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr. 1984;40:1146-1155.
  30. ↵
    Anderson JW, Gilinsky NH, Deakins DA, Smith SF, O’Neal DS, Dillon DW, Oeltgen PR. Lipid responses of hypercholesterolemic men to oat bran and wheat bran intake. Am J Clin Nutr. 1991;54:678-683.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Anderson JW, Gustafson NJ, Spencer DB, Tietyen J, Bryant CA. Serum lipid response of hypercholesterolemic men to single and divided doses of canned beans. Am J Clin Nutr. 1990;51:1013-1019.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Anderson JW, Story L, Sieling B, Chen W-JL. Hypocholesterolemic effects of high-fiber diets rich in water-soluble plant fibers: long term studies with oat bran and bean-supplemented diets for hypercholesterolemic men. J Cancer Diet Assoc. 1984;45:140-149.
  33. ↵
    Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med. 1988;148:292-296.
    OpenUrlCrossRefPubMed
  34. ↵
    Jenkins DJ, Reynolds D, Leeds AR, Waller AL, Cummings JH. Hypocholesterolemic action of dietary fiber unrelated to fecal bulking effect. Am J Clin Nutr.. 1979;32:2430-2435.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Miettinen TA, Tarpila S. Effect of pectin on serum cholesterol, fecal bile acids and bilary lipids in normolipidemic and hyperlipidemic individuals. Clin Chem Acta. 1977;70:471-477.
    OpenUrl
  36. ↵
    Ripsin CM, Keenan JM, Jacobs DR Jr, Elmer PJ, Welch RR, Van Horn L, Liu K, Turnbull WH, Thye FW, Kestin M, Hegsted M, Davidson DM, Davidson MH, Dugan LD, Demark-Wahnefried W, Beling S. Oat products and lipid lowering: a meta-analysis. JAMA. 1992;267:3317-3325.
    OpenUrlCrossRefPubMed
  37. ↵
    Poulter N, Chang CL, Cuff A, Poulter C, Sever P, Thom S. Lipid profiles after the daily consumption of oat-based cereal: a controlled crossover trial. Am J Clin Nutr. 1993;58:66-69.
    OpenUrl
  38. ↵
    Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med. 1990;322:147-152.
    OpenUrlPubMed
  39. ↵
    Zhang JX, Hallmans G, Andersson H, Bosaeus I, Aman P, Tidehag P, Stenling R, Lundin E, Dahlgren S. Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr.. 1992;56:99-105.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Food and Drug Administration, Docket 95P-0197. Food Labeling Health Claims, Oats and Coronary Heart Disease. Federal Register. 1996;61(3).
  41. ↵
    Hunninghake DB, Miller VT, LaRosa JC, Kinosian B, Jacobson T, Brown V, Howard WJ, Edelman DA, O’Connor RR. Long-term treatment of hypercholesterolemia with dietary fiber. Am J Med. 1994;97(6):504-508.
  42. ↵
    Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996;275:447-451.
    OpenUrlCrossRefPubMed
  43. ↵
    Ziegler RG. Vegetables, fruits, and the carotenoids and the risk of cancer. Am J Clin Nutr. 1991;53(suppl):251S-259S.
  44. ↵
    Dobson PM, Pacy PJ, Cox EV. Long-term follow-up of the treatment of essential hypertension with a high-fiber, low-fat and low-sodium dietary regimen. Hum Nutr Clin Nutr. 1985;39C:213-220.
  45. ↵
    Rouse IL, Armstrong BK, Beilin LJ. The relationship of blood pressure to diet and lifestyle in two religious populations. J Hypertens. 1983;1:65-71.
    OpenUrlPubMed
  46. ↵
    Rouse IL, Beilin LJ, Mahoney DP, Margetts BM, Armstrong BK, Record SJ, Vandongen R, Barden A. Nutrient intake, blood pressure, serum and urinary prostaglandins and serum thromboxane B2 in a controlled trial with a lacto-ovo-vegetarian diet. J Hypertens. 1986;4:241-250.
    OpenUrlCrossRefPubMed
  47. ↵
    Margetts BM, Beilin LJ, Armstrong BK, Vandongen R. A randomized controlled trial of a vegetarian diet in the treatment of mild hypertension. Clin Exp Pharmacol Physiol. 1985;12:263-266.
    OpenUrlPubMed
  48. ↵
    Margetts BM, Beilin LJ, Vandongen R, Armstrong BK. A randomized controlled trial of the effect of dietary fiber on blood pressure. Clin Sci. 1987;72:343-350.
    OpenUrlPubMed
  49. ↵
    Rössner S, von Zweigbergk D, Ohlin A, Ryttig K. Weight reduction with dietary fibre supplements: results of two double-blind randomized studies. Acta Med Scand. 1987;222:83-88.
    OpenUrlPubMed
  50. ↵
    Kahn HA, Phillips RL, Snowdon DA, Choi W. Association between reported diet and all-cause mortality: twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists. Am J Epidemiol. 1984;119:775-787.
    OpenUrlAbstract/FREE Full Text
  51. ↵
    Anderson JW. High-fiber diets for obese diabetic men on insulin therapy: short-term and long-term effects. In: Vahouny GV, ed. Dietary Fiber and Obesity. New York, NY: Alan R Liss, Inc; 1985:133-159.
  52. ↵
    Williams CL, Bollella M, Wynder EL. A new recommendation for dietary fiber in childhood. Pediatrics. 1995;96:985-988.
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Alaimo K, McDowell M, Briefel R, Bischof A, Caughman C, Loria C, Johnson C. Dietary intake: vitamins, minerals and fiber of persons age two months and over in the United States: third National Health and Nutrition Examination Survey: phase 1, 1988-91. Advance Data.. 1994;258:1-28.
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation
June 17, 1997, Volume 95, Issue 12
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • What Is Dietary Fiber?
    • Sources of Dietary Fiber
    • Mechanisms of Serum Cholesterol Reduction
    • Fiber Intake and Mortality
    • Results of Clinical and Metabolic Studies
    • Effects of Fiber on Other Risk Factors
    • Fiber and Children’s Diets
    • Conclusions
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Fiber, Lipids, and Coronary Heart Disease
    Linda Van Horn
    Circulation. 1997;95:2701-2704, originally published June 17, 1997
    https://doi.org/10.1161/01.CIR.95.12.2701

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Fiber, Lipids, and Coronary Heart Disease
    (Your Name) has sent you a message from Circulation
    (Your Name) thought you would like to see the Circulation web site.
  • Share on Social Media
    Fiber, Lipids, and Coronary Heart Disease
    Linda Van Horn
    Circulation. 1997;95:2701-2704, originally published June 17, 1997
    https://doi.org/10.1161/01.CIR.95.12.2701
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured